Artificial Intelligence company BenevolentAI has bought a drug discovery and development facility at the Babraham Research Campus in Cambridge for an undisclosed sum.
A new report commissioned by the Association of the British Pharmaceutical Industry (ABPI) has found that hospitals engaging in industry partnerships are up to 2.5 times more likely to foll